Chinese study shows heterologous booster shot increases protective effect
BEIJING -- A Chinese study has shown that having a different vaccine as the booster shot can increase the protective effect against the COVID-19 virus.
In the study, adults who had received two doses of the inactivated vaccine CoronaVac in the past three to six months were vaccinated with Convidecia, the adenovirus type-5 vector-based COVID-19 vaccine or a third dose of CoronaVac.
The post-vaccination geometric mean titer (GMT) is a key immunological parameter adequately expressing antibody response after vaccination.
According to the study published in the journal Nature Medicine, the GMT of neutralizing antibody against SARS-CoV-2 was 197.4 after Convidecia was given as the booster shot, while the GMT was 33.6 when the third dose of CoronaVac was given.
The researchers said that the data suggest heterologous boosting with Convidecia following initial vaccination with CoronaVac is safe and more effective than homologous boosting.
- Global engineering congress to be held in Shanghai
- 'Lingka' custom in Xizang evolves into new form of cultural tourism, vibrant lifestyle
- From logging to guardianship: How China protects green source of its 'mother river'
- China rescues 10 Myanmar seafarers in South China Sea
- Qingdao sees surge in travelers to S Korea under its temporary visa-free policy
- China's 2025 box office surpasses 2024's full-year gross
